Urinary N-telopeptides to monitor bone resorption while on GnRH agonist therapy

Obstetrics and Gynecology

Volumn 87, Issue 3, 1996, Pages 350-354

  Marshall, Lorna A ^a   Cain, Daniel F ^b   Dmowski, W P ^b   Chesnut III, Charles H ^b  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST;

ADULT; ARTICLE; BONE ATROPHY; BONE MINERAL; DIAGNOSTIC ACCURACY; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; LEIOMYOMA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OSTEOLYSIS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE DIAGNOSIS;

EID: 0029983139     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(95)00424-6     Document Type: Article

References (16)

1. Dodin S, Lemay A, Maheux R, Dumont M, Turcot-Lemay L. Bone mass in endometriosis patients treated with GnRH agonist implant or danazol. Obstet Gynecol 1991;77:410-5.
2. Raven P, Bergqvist A, Hansen MA, Overgaard K, Christiansen C. Treatment of endometriosis with the luteinizing hormone-releasing hormone agonist nafarelin. Effect on bone turnover and bone mass. Menopause 1994;1:11-7.
3. Johansen JS, Riis BJ, Hassager C, Moen M, Jacobson J, Christiansen C. The effect of a gonadotropin-releasing hormone agonist analog (nafarelin) on bone metabolism. J Clin Endocrinol Metab 1988;67: 701-6.
4. Gudmundsson JA, Ljunghall S, Bergqvist C, Wide L, Nillius NJ. Increased bone turnover during gonadotrophin-releasing hormone superagonist-induced ovulation inhibition. J Clin Endocrinol Metab 1987;65:159-63.
5. Compston JE, Yamaguchi K, Croucher PI, Garrahan NJ, Lindsay PC, Shaw RW. The effects of gonadotrophin-releasing hormone agonists on iliac crest cancellous bone structure in women with endometriosis. Bone 1995;16:261-7.
6. Friedman AJ, Daly M, Juneau-Norcross M, Gleason R, Rein MS, LeBoff M. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri. J Clin Endocrinol Metab 1993;76:1439-45.
7. Surrey ES, Judd HL. Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: A prospective randomized trial. J Clin Endocrinol Metab 1992;75:558-63.
8. Rosen HN, Dresner-Pollak R, Moses AC, et al. Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover. Calcif Tissue Int 1994;54:26-9.
9. Hanson DA, Weiss MA, Bollen AM, Maslan SL, Singer FR, Eyre DR. A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 1992;7:1251-8.
10. Garnero P, Shih WJ, Gineyts E, Karpt DB, Delmas PD. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 1994;79:1693-700.
11. Gertz BJ, Shao P, Hanson DA, et al. Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine. J Bone Miner Res 1994;9:135-42.
12. Campodarve I, Ulrich U, Bell N, et al. Urinary N-telopeptide of type 1 collagen monitors bone resorption and may predict change in bone mass of the spine in response to hormone replacement therapy. J Bone Miner Res 1995;10(Suppl):P215.
13. Chesnut CH III. The imaging and quantitation of bone by radiographic and scanning methodologies. In: Coe FL, Favus MJ, eds. Disorders of bone and mineral metabolism. New York: Raven Press, 1992:443-54.
14. Sugimoto AK, Hodsman AB, Nisker JA. Long-term gonadotropin-releasing hormone agonist with standard postmenopausal estrogen replacement failed to prevent vertebral bone loss in premenopausal women. Fertil Steril 1993;60:672-4.
15. Finkelstein JS, Klibanske A, Schaefer EH, Hornstein MD, Schiff I, Neer RM. Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. N Engl J Med 1994;331:1618-23.
16. Prestwood KM, Pilbeam CC, Burleson JA, et al. The short-term effects of conjugated estrogen on bone turnover in older women. J Clin Endocrinol Metab 1994;79:366-71.